Tricyclic Antidepressant Overdose

Topic Overview

Summary

Tricyclic antidepressant (TCA) overdose is a life-threatening toxicological emergency requiring immediate recognition and aggressive management. TCAs remain a significant cause of poisoning-related morbidity and mortality despite decreasing prescription rates, with over 12,000 reported exposures annually in the United States. [1]

The toxicity profile is driven by three principal mechanisms: sodium channel blockade (causing cardiac dysrhythmias and QRS widening), anticholinergic effects (central and peripheral), and alpha-adrenergic blockade (peripheral vasodilation and hypotension). [2] The classic triad comprises altered consciousness, seizures, and cardiac arrhythmias, though patients may deteriorate rapidly from apparent stability to cardiac arrest within minutes.

QRS prolongation > 100ms on the electrocardiogram is a critical predictor of major toxicity, with sensitivity of 82% for seizures or ventricular arrhythmias. [3] Treatment is primarily supportive with sodium bicarbonate as first-line therapy for QRS widening and arrhythmias, benzodiazepines for seizure control, and IV fluid resuscitation. Mortality approaches 5% in severe overdoses but can be minimized with prompt recognition and appropriate treatment. [2,4]

Key Facts

• Multiple mechanisms: Sodium channel blockade + anticholinergic effects + alpha-blockade + GABA antagonism + potassium channel effects
• Toxic dose: > 10 mg/kg (moderate toxicity); > 20 mg/kg (potentially fatal)
• Key ECG predictor: QRS > 100ms = increased risk seizures/arrhythmias; QRS > 160ms = high risk ventricular arrhythmias
• Terminal R wave in aVR: ≥3mm is independent predictor of severe toxicity [3]
• First-line treatment: Sodium bicarbonate (target pH 7.50-7.55) for QRS widening and arrhythmias [5]
• Contraindicated: Flumazenil (lowers seizure threshold), Class Ia/Ic antiarrhythmics (worsen sodium channel blockade), physostigmine (may cause asystole)
• Timeline: Symptoms typically within 1-2 hours; most deaths occur within first 6 hours of ingestion [2]
• Observation period: Minimum 6 hours of cardiac monitoring if asymptomatic

Clinical Pearls

QRS duration as predictor: QRS > 100ms predicts seizures (sensitivity 82%); QRS > 160ms strongly predicts ventricular arrhythmias [3]

Sodium bicarbonate mechanism: Dual action via (1) increased extracellular sodium gradient overcomes sodium channel blockade, and (2) alkalinization reduces TCA binding to sodium channels [5,6]

The "dirty drug" concept: TCAs affect multiple receptor systems simultaneously, producing overlapping toxidromes that complicate clinical presentation

Terminal 40ms axis: Rightward deviation of terminal 40ms QRS axis in frontal plane (prominent R wave in aVR) is more sensitive than QRS widening alone [3]

Lipid emulsion rescue: Intravenous lipid emulsion may be considered as rescue therapy in cardiac arrest refractory to conventional treatment, though evidence is limited to case reports [7]

Prolonged CPR worthwhile: TCA toxicity is potentially reversible; successful neurological recovery reported after > 90 minutes CPR [8]

Why This Matters Clinically

TCA overdose represents a true toxicological emergency where minutes matter. Patients may appear relatively well initially but deteriorate to cardiac arrest within 30-60 minutes. Early identification of ECG markers of toxicity (QRS widening, R wave in aVR) and prompt administration of sodium bicarbonate can be life-saving. The condition requires continuous cardiac monitoring, anticipation of seizures and arrhythmias, and readiness for advanced life support. Despite effective antidotes being available, TCA overdose remains a leading cause of fatal poisoning globally.

---

Visual Summary

Visual assets to be added:

• TCA mechanism of toxicity diagram (sodium channel blockade, anticholinergic, alpha-blockade)
• ECG progression showing QRS widening, R wave in aVR, rightward terminal 40ms axis
• TCA overdose management algorithm (from presentation to disposition)
• Anticholinergic toxidrome clinical features
• Sodium bicarbonate dosing and monitoring protocol
• Comparison of toxic doses across different TCAs

---

Epidemiology

Incidence and Prevalence

• Annual exposures: Over 12,000 TCA exposures reported to US poison centers in 2004, with approximately 20% requiring hospital admission [1]
• Decreasing trend: TCA prescribing has declined significantly since introduction of SSRIs, but TCAs remain disproportionately represented in fatal overdoses
• Case fatality: Mortality approximately 1-2% of all exposures but 5% in severe overdoses requiring intensive care [4]
• Age distribution: Most overdoses occur in adults 20-50 years; accidental paediatric exposures have better prognosis due to lower ingested doses

Most Common TCAs and Relative Toxicity

Risk Factors for Severe Toxicity

• Dose ingested: > 10 mg/kg associated with moderate-severe toxicity; > 20 mg/kg potentially fatal [1]
• Co-ingestion: Alcohol, benzodiazepines, other cardiotoxic drugs increase morbidity
• Delayed presentation: > 2 hours post-ingestion with no gastric decontamination
• Pre-existing cardiac disease: Conduction abnormalities, ischaemic heart disease
• Acidosis: Respiratory or metabolic acidosis increases free TCA fraction and toxicity
• Extremes of age: Elderly patients more susceptible; young children have better outcomes relative to dose

---

Pathophysiology

Multiple Mechanisms of Toxicity — The "Dirty Drug"

TCAs exert their toxic effects through actions at multiple receptor and ion channel sites, producing a complex clinical picture:

Exam Detail: ### Detailed Molecular Mechanisms

Sodium Channel Blockade (Primary Cardiotoxicity Mechanism):

TCAs bind to the alpha subunit of voltage-gated sodium channels (Nav1.5) in cardiac myocytes, particularly in the open and inactivated states. This "use-dependent" blockade:

• Slows phase 0 depolarization of cardiac action potential
• Prolongs phase 1 and early phase 2 (QRS widening on ECG)
• Delays intraventricular conduction
• Increases refractory period
• Impairs His-Purkinje conduction
• Creates substrate for re-entrant ventricular arrhythmias [10]

The blockade is pH-dependent: acidosis increases the ionized (charged) fraction of TCA, which paradoxically increases tissue binding and toxicity. Alkalinization with sodium bicarbonate reduces the proportion of ionized TCA, decreasing sodium channel binding. [6]

Pharmacokinetic Alterations in Overdose:

• Absorption: Delayed and prolonged due to anticholinergic effects on gastric emptying; enterohepatic recirculation prolongs elimination [12]
• Distribution: Large volume of distribution (10-50 L/kg); highly lipophilic; crosses blood-brain barrier readily
• Protein binding: > 90% bound to albumin and alpha-1 acid glycoprotein; acidosis increases free (unbound) fraction
• Metabolism: Hepatic hydroxylation can become saturated in overdose, converting first-order to zero-order kinetics [12]
• Elimination half-life: Typically 10-80 hours but may be prolonged to days in massive overdose

Why Sodium Bicarbonate Works: Dual Mechanism

Sodium bicarbonate is the cornerstone of TCA cardiotoxicity management due to two synergistic mechanisms: [5,6]

1. Increased serum sodium concentration:

   • Increases extracellular sodium gradient across cardiac myocyte membranes
   • Overcomes competitive sodium channel blockade by TCA
   • "Pushes" sodium ions through partially blocked channels
   • Restores normal phase 0 depolarization velocity

2. Alkalinization (target pH 7.50-7.55):

   • Reduces ionized (charged) fraction of TCA molecules
   • Decreases TCA binding affinity to sodium channels
   • Shifts TCA from myocardium to plasma compartment
   • Reduces free drug concentration in tissues

Important: The sodium load appears more important than alkalinization alone, as hypertonic saline (3%) has shown similar efficacy in experimental models. [6] However, sodium bicarbonate provides both mechanisms simultaneously.

---

Clinical Presentation

Timeline of Toxicity

Classic Triad of Severe TCA Toxicity

1. Altered consciousness — ranging from agitation/delirium to lethargy, stupor, or coma
2. Seizures — typically generalized tonic-clonic; may be single or multiple
3. Cardiac dysrhythmias — wide complex tachycardia, ventricular tachycardia, ventricular fibrillation, or asystole

Anticholinergic Toxidrome — "Mad as a Hatter, Blind as a Bat, Red as a Beet, Hot as a Hare, Dry as a Bone"

Central Effects

• Agitation, confusion, delirium
• Hallucinations (typically visual)
• Mumbling speech
• Picking at bedclothes (carphology)
• Seizures
• Coma (in severe cases)

Peripheral Effects

• Ocular: Mydriasis (dilated pupils), blurred vision, loss of accommodation
• Cardiovascular: Sinus tachycardia (may be only early sign)
• Skin: Flushed, dry, warm; absent sweating
• Mucous membranes: Dry mouth, dry tongue
• Gastrointestinal: Reduced bowel sounds, ileus
• Genitourinary: Urinary retention, palpable bladder
• Temperature: Hyperthermia (may be severe, > 41°C)

Cardiovascular Manifestations

ECG Changes (in order of severity)

Arrhythmias

• Supraventricular: Sinus tachycardia (universal), atrial fibrillation/flutter (uncommon)
• Atrioventricular block: 1st degree (common), 2nd/3rd degree (severe toxicity)
• Ventricular: Ventricular tachycardia (wide complex, regular), ventricular fibrillation, Torsades de Pointes (rare)
• Bradyarrhythmias: Sinus bradycardia (terminal event), junctional rhythm, asystole

Hypotension

Results from combination of mechanisms:

• Alpha-1 adrenergic blockade → peripheral vasodilation
• Negative inotropy from sodium channel blockade
• Relative hypovolemia from vasodilation
• May be refractory to fluid resuscitation and standard vasopressors

Neurological Manifestations

Respiratory Effects

• Respiratory depression: Direct CNS depression; may require mechanical ventilation
• Aspiration pneumonitis: Risk increased by altered consciousness and reduced gag reflex
• Pulmonary oedema: Rare; non-cardiogenic (ARDS pattern) or cardiogenic

Red Flags for Severe Toxicity

---

Clinical Examination

Systematic Approach to TCA Overdose Patient

General Appearance

• Level of consciousness (GCS score)
• Degree of agitation vs sedation
• Respiratory pattern and effort
• Skin appearance (flushed, dry, diaphoretic)

Vital Signs

• Heart rate: Usually tachycardic (> 100 bpm); bradycardia is ominous sign
• Blood pressure: May be normal early, then hypotensive
• Respiratory rate: May be depressed or tachypnoeic (compensating for metabolic acidosis)
• Temperature: Check for hyperthermia (> 38.5°C suggests severe anticholinergic toxicity)
• Oxygen saturation: Hypoxia suggests respiratory depression or aspiration

Eyes

• Pupils: Mydriasis (dilated) due to anticholinergic effects; assess reactivity
• Nystagmus: May be present with severe CNS toxicity
• Sclera: Assess for jaundice (co-ingestion, underlying liver disease)

Cardiovascular

• Pulse: Rate, rhythm, character
• Blood pressure: Both arms if possible; postural change
• JVP: Assess volume status
• Heart sounds: Listen for murmurs (pre-existing disease)
• Peripheral perfusion: Capillary refill, peripheral pulses

Respiratory

• Respiratory rate and pattern: Cheyne-Stokes pattern in severe toxicity
• Work of breathing: Use of accessory muscles
• Chest auscultation: Assess for aspiration, pulmonary oedema
• Airway protection: Gag reflex, ability to protect airway

Neurological

• GCS: Document clearly; trend over time
• Pupils: Size, reactivity, symmetry
• Tone: Increased tone or rigidity suggests severe toxicity
• Reflexes: Brisk reflexes may be present; clonus
• Plantar responses: Extensor plantars with CNS depression

Abdomen

• Bowel sounds: Reduced or absent (anticholinergic effect)
• Bladder: Palpable bladder suggests urinary retention
• Tenderness: Assess for trauma, co-ingestion

Skin

• Color: Flushed and red (anticholinergic)
• Temperature: Warm or hot to touch
• Moisture: Dry skin and dry axillae (pathognomonic for anticholinergic toxicity)
• Pressure areas: If prolonged unconsciousness

---

Investigations

ECG — THE CRITICAL INVESTIGATION

Obtain 12-lead ECG immediately on presentation and continuous cardiac monitoring

Key Measurements and Interpretation

Specific ECG Patterns in TCA Toxicity

1. Terminal 40ms QRS axis: Measure axis of terminal 40ms of QRS in frontal plane

   • Normal: Leftward or superior
   • TCA toxicity: Rightward deviation (> 120°)
   • Creates prominent R wave in lead aVR, S wave in lead I

2. Brugada pattern: Type 1 pattern (coved ST elevation ≥2mm in V1-V3 + RBBB) reported with TCA toxicity [11]

3. Torsades de Pointes: Polymorphic VT with QT prolongation; uncommon compared to monomorphic VT

ECG Monitoring Strategy

• Continuous monitoring: All patients for minimum 6 hours
• Serial 12-lead ECGs: Every 1-2 hours until QRS normalizing and patient stable
• Extended monitoring: 24 hours if any ECG abnormality or severe ingestion
• Discharge criteria: Normal ECG and asymptomatic for 6 hours post-ingestion

Blood Tests

Essential Investigations

Arterial Blood Gas — Critical for Management

Respiratory or metabolic acidosis significantly worsens TCA toxicity by increasing the ionized fraction of TCA, enhancing tissue binding. [6]

• Target pH: 7.45-7.55 (mild alkalosis protective)
• Causes of acidosis to correct:
  • "Respiratory: Hypoventilation, respiratory depression, aspiration"
  • "Metabolic: Seizures (lactic acidosis), poor perfusion, sodium bicarbonate therapy depleting buffer"
• Management: Intubation and hyperventilation if pH less than 7.30 despite bicarbonate therapy

TCA Serum Concentrations — Limited Clinical Utility

• Availability: Not widely or rapidly available in most hospitals
• Poor correlation: Serum levels correlate poorly with clinical toxicity [1]
• Timing issues: Single levels difficult to interpret due to delayed/erratic absorption
• Clinical assessment superior: ECG findings (QRS duration, R in aVR) are better predictors than levels [3]
• Not recommended: Should not delay or guide management

Other Investigations

---

Classification & Staging

Severity Classification of TCA Overdose

Note: Clinical features and ECG findings are better predictors than estimated dose, as history may be unreliable.

Stages of Poisoning (Historical Classification)

---

Management

Principles of TCA Overdose Management

1. Supportive care is the foundation: ABC approach, continuous monitoring
2. Sodium bicarbonate for QRS widening and arrhythmias (evidence-based, first-line) [5]
3. Avoid proarrhythmic agents (Class Ia/Ic antiarrhythmics) and drugs that lower seizure threshold (flumazenil, physostigmine in TCA overdose)
4. Anticipate rapid deterioration: Have resuscitation equipment immediately available
5. Prolonged resuscitation worthwhile: TCA toxicity reversible; continue CPR longer than usual [8]

Initial Resuscitation and Stabilization

Immediate Actions (First 5 Minutes)

Enhanced Elimination

Activated Charcoal

• Indication: Presentation within 1-2 hours of ingestion AND patient able to protect airway or intubated
• Dose: 50g (adults) or 1g/kg (children) orally or via nasogastric tube
• Contraindications: Unprotected airway (GCS less than 9), bowel obstruction, perforation risk
• Efficacy: TCAs highly adsorbed by activated charcoal; effective if given early [13]
• Multi-dose: Not routinely recommended (minimal evidence, risk of aspiration)

Gastric Lavage

• Rarely indicated: Only if massive, life-threatening ingestion presenting within 1 hour
• Requirements: Intubated patient with large-bore orogastric tube
• Risks: Aspiration, esophageal perforation, vagal stimulation (arrhythmias)

Extracorporeal Removal

• Hemodialysis: NOT effective (TCAs highly protein-bound, large volume of distribution)
• Hemoperfusion: NOT effective (same reasons)
• Plasmapheresis: Case reports of use in refractory cases [7]; not standard of care

Sodium Bicarbonate Therapy — FIRST-LINE FOR CARDIAC TOXICITY

Exam Detail: #### Evidence Base

Sodium bicarbonate is the best-evidenced antidote for TCA-induced cardiac toxicity, supported by:

• Multiple animal models showing improved survival and QRS narrowing [6]
• Prospective clinical cohort showing reversal of arrhythmias and QRS widening [5]
• Position statements from toxicology societies recommending first-line use [1]

Indications for Sodium Bicarbonate

Dosing Regimen

Initial bolus:

• Adults: 50-100 mmol (50-100mL of 8.4% solution) IV over 2-3 minutes
• Children: 1-2 mmol/kg (1-2mL/kg of 8.4% solution) IV over 2-3 minutes

Repeat boluses:

• May repeat every 3-5 minutes if QRS remains wide or arrhythmias persist
• Titrate to QRS narrowing, arrhythmia resolution, or target pH achieved

Infusion (if ongoing need):

• Add 100-150 mmol (100-150mL of 8.4%) to 850mL D5W = isotonic bicarbonate solution
• Infuse at 1.5-2× maintenance rate
• Aim to maintain pH 7.50-7.55

Monitoring During Bicarbonate Therapy

• Arterial pH: Check ABG every 30-60 minutes initially
  • "Target: 7.50-7.55 (mild alkalosis)"
  • Do NOT exceed pH 7.60 (risk of alkalosis complications)
• Serum potassium: Check every 2-4 hours
  • Alkalosis drives potassium intracellularly → hypokalemia
  • Maintain K⁺ > 3.5 mmol/L (supplement aggressively)
• Serum calcium: Alkalosis reduces ionized calcium
  • Check if tetany, prolonged QT, or ionized Ca²⁺ less than 1.0 mmol/L
• Serial ECGs: QRS duration should narrow within 10-20 minutes if bicarbonate effective

Alternative: Hypertonic Saline

• Indication: If bicarbonate ineffective or not available
• Dose: 3% saline 100-150mL bolus over 10-15 minutes
• Mechanism: Increased serum sodium overcomes sodium channel blockade [6]
• Evidence: Animal models suggest similar efficacy to bicarbonate for cardiac effects
• Limitation: Does NOT provide alkalinization benefit

Seizure Management

Rationale for benzodiazepines: Enhance GABAergic inhibition, counteracting TCA-induced GABA antagonism.

Hypotension Management

Stepwise Approach

1. IV fluid bolus: 500-1000mL crystalloid (may need 2-3L total)
2. Sodium bicarbonate: Bolus therapy (improves cardiac contractility)
3. Correct acidosis: Target pH > 7.45 (acidosis worsens hypotension)
4. Vasopressor support if refractory to above:

AVOID: Pure alpha-agonists (e.g., phenylephrine) — less effective due to direct myocardial depression.

Arrhythmia Management

Specific Arrhythmia Treatment

Agents to AVOID in TCA Arrhythmias

Safe Agents for TCA Arrhythmias

• Sodium bicarbonate: First-line (described above)
• Lidocaine: Class Ib antiarrhythmic; weak sodium channel blocker; may be used for refractory VT (1-1.5 mg/kg bolus)
• Magnesium sulfate: For Torsades de Pointes specifically (2g IV over 10 minutes)

Cardiac Arrest Management — Special Considerations

TCA-induced cardiac arrest has important differences from standard ACLS:

1. Prolonged resuscitation worthwhile: Case reports of full neurological recovery after > 90 minutes CPR [8]

   • Toxicity is potentially reversible
   • Continue CPR longer than standard 20-30 minutes

2. Sodium bicarbonate during CPR:

   • Give 50-100 mmol boluses every 3-5 minutes during resuscitation
   • May restore organized rhythm

3. Epinephrine: Standard ACLS doses (1mg every 3-5 minutes)

4. Defibrillation: Standard energy levels for VF/pulseless VT

5. Avoid: Vasopressin as sole vasopressor (use epinephrine or norepinephrine)

6. Consider:

   • Intravenous lipid emulsion (ILE): 20% lipid emulsion bolus (1.5 mL/kg over 1 minute) then infusion (0.25 mL/kg/min) for refractory cardiac arrest [7]
     • Evidence: Case reports only; mechanism unclear (lipid sink theory, direct cardiac effects)
     • Risk: Lipid interference with lab tests, pancreatitis, fat embolism
     • Position: Rescue therapy only when conventional treatment failing
   • ECMO (extracorporeal membrane oxygenation): Case reports of successful bridging to recovery in refractory cardiac arrest
     • Requires ECMO-capable center
     • Consider early transfer if near ECMO center

Drugs to AVOID in TCA Overdose

Adjunctive and Emerging Therapies

Intravenous Lipid Emulsion (ILE)

• Formulation: 20% lipid emulsion (Intralipid® or equivalent)
• Proposed mechanism: "Lipid sink" — sequesters lipophilic TCA molecules in intravascular lipid phase, reducing tissue concentrations
• Evidence: Case reports and series showing reversal of refractory hypotension and cardiac arrest [7]
• Dosing (if used):
  • "Bolus: 1.5 mL/kg (lean body weight) IV over 1 minute"
  • "Infusion: 0.25 mL/kg/min for 30-60 minutes"
  • May repeat bolus and continue infusion if ongoing instability
• Indications: Rescue therapy for cardiac arrest or severe cardiovascular collapse unresponsive to sodium bicarbonate and vasopressors
• Risks: Acute pancreatitis, fat embolism, interference with lab tests, allergic reactions
• Current status: NOT first-line; consider in extremis situations

Plasmapheresis

• Rationale: Remove TCA from plasma (though highly protein-bound and large Vd limit efficacy)
• Evidence: Single case report of successful use as adjunct [7]
• Practicality: Requires specialized equipment, not rapidly available
• Current status: Experimental only; not recommended

Monitoring and Observation

Intensive Care Unit (ICU) Admission Criteria

Admit to ICU if ANY of the following:

• QRS ≥100ms
• Seizures
• Ventricular arrhythmias
• Hypotension requiring vasopressors
• Altered consciousness (GCS less than 13)
• Respiratory depression
• Need for intubation
• Recurrent symptoms after initial improvement

Emergency Department Observation

Patients may be observed in ED/clinical decision unit if:

• Asymptomatic or mild anticholinergic features only
• QRS less than 100ms on all ECGs
• No seizures or arrhythmias
• Normal vital signs
• Reliable history of ingestion less than 10 mg/kg
• Presentation within 2 hours and received activated charcoal

Observation period: Minimum 6 hours of continuous cardiac monitoring from time of ingestion or presentation (whichever later)

Serial Monitoring Requirements

Discharge Criteria

All criteria must be met:

• Asymptomatic for ≥6 hours post-ingestion
• Normal ECG (QRS less than 100ms, no arrhythmias) on ≥2 consecutive ECGs 2 hours apart
• Normal vital signs
• Normal mental status
• Psychiatric clearance (deliberate self-harm cases)
• No co-ingestions requiring ongoing treatment
• Safe discharge environment

Follow-up: Psychiatric assessment and follow-up for deliberate self-harm; cardiology follow-up if prolonged QTc persists at discharge.

---

Complications

Immediate Complications (Within 24 Hours)

Intermediate Complications (24 Hours - 7 Days)

Long-Term Complications

Complications of Treatment

---

Prognosis & Outcomes

Overall Prognosis

Excellent if treated promptly and appropriately:

• Mortality less than 1% overall across all TCA exposures [4]
• Mortality 2-5% in severe overdoses requiring ICU admission [4]
• Most deaths occur within first 6 hours of ingestion [2]
• If patient survives first 24 hours, prognosis is excellent

Factors Associated with Poor Prognosis

Factors Associated with Good Prognosis

• Presentation within 2 hours with gastric decontamination
• QRS less than 100ms throughout observation period
• No seizures or arrhythmias
• Prompt treatment with sodium bicarbonate when indicated
• Absence of significant co-ingestions
• Young, otherwise healthy patient

Neurological Recovery After Cardiac Arrest

• Full recovery possible even after prolonged resuscitation (> 60-90 minutes CPR) [8]
• TCA toxicity is reversible; do not declare futile prematurely
• Standard post-cardiac arrest care (targeted temperature management, neuroprognostication at 72+ hours)

Long-Term Outcomes

• Complete recovery expected in patients who survive acute phase
• No long-term cardiac sequelae if acute toxicity resolves
• Psychiatric follow-up essential (high risk repeat self-harm)
• Switching to safer antidepressant (SSRI) strongly recommended if TCAs still needed

Predictors of Successful Outcome

1. Early recognition and continuous cardiac monitoring
2. Prompt sodium bicarbonate for QRS widening
3. Aggressive seizure control
4. Avoidance of proarrhythmic drugs
5. Prolonged resuscitation efforts if cardiac arrest occurs

---

Prevention & Public Health

Primary Prevention

• Prescribing practices: Prescribe SSRIs (safer in overdose) as first-line for depression; reserve TCAs for specific indications (neuropathic pain, treatment-resistant depression)
• Quantity limits: Prescribe smallest quantity necessary (1-2 weeks supply) in high-risk patients
• Risk assessment: Identify suicidal ideation before prescribing; consider supervised dispensing
• Patient education: Counsel on overdose risk, safe storage, keeping medications away from children

Secondary Prevention (Early Detection)

• Mental health screening: Regular assessment of patients prescribed TCAs
• Early signs of deliberate self-harm: Stockpiling medications, giving away possessions
• Family education: Recognize warning signs, safe storage of medications

Tertiary Prevention (Reducing Harm After Exposure)

• Public awareness: Immediate presentation to ED after overdose
• Poison center utilization: Early contact with toxicology services
• Psychiatric follow-up: Mandatory after deliberate self-harm to reduce repeat attempts

---

Evidence & Guidelines

Key Clinical Guidelines

1. Woolf AD, et al. Tricyclic antidepressant poisoning: an evidence-based consensus guideline for out-of-hospital management. Clin Toxicol. 2007;45(3):203-233. [1]

   • Evidence-based expert consensus for prehospital and ED management
   • Recommends ECG monitoring for all suspected TCA ingestions
   • Supports sodium bicarbonate for QRS ≥100ms

2. American Academy of Clinical Toxicology (AACT) / European Association of Poisons Centres and Clinical Toxicologists (EAPCCT) position statements

   • Activated charcoal: Single dose within 1 hour of ingestion if airway protected
   • Gastric lavage: Rarely indicated, only if massive life-threatening ingestion within 1 hour
   • Do not use ipecac

3. TOXBASE (UK National Poisons Information Service)

   • Primary UK resource for TCA overdose management
   • Regularly updated with current evidence
   • 24/7 phone support via National Poisons Information Service

Key Landmark Studies

4. Kerr GW, et al. Tricyclic antidepressant overdose: a review. Emerg Med J. 2001;18(4):236-241. [2]

   • Comprehensive review of TCA toxicity mechanisms
   • Documents 5% mortality in severe overdoses
   • Classic triad: altered consciousness, seizures, arrhythmias

5. Boehnert MT, Lovejoy FH Jr. Value of the QRS duration versus the serum drug level in predicting seizures and ventricular arrhythmias after an acute overdose of tricyclic antidepressants. N Engl J Med. 1985;313(8):474-479. [3]

   • Landmark study establishing QRS > 100ms as predictor of toxicity
   • Sensitivity 82% for seizures/arrhythmias
   • Serum levels do not correlate with toxicity

6. Bruccoleri RE, Burns MM. A literature review of the use of sodium bicarbonate for the treatment of QRS widening. J Med Toxicol. 2016;12(1):121-129. [5]

   • Systematic review of sodium bicarbonate efficacy
   • Supports use for QRS widening in TCA and other sodium channel blockers
   • Describes dual mechanism: increased sodium and alkalinization

Mechanistic Studies

7. Hoffman JR, et al. The effects of sodium bicarbonate in treating tricyclic antidepressant-induced arrhythmias in dogs. J Toxicol Clin Toxicol. 1993;31(4):573-586. [6]
   • Animal model demonstrating sodium bicarbonate efficacy
   • Both hypernatremia and alkalosis contribute to benefit
   • Hypertonic saline also effective (sodium load most important)

Case Reports and Series

8. Thour A, Marwaha R. Amitriptyline. StatPearls. 2024. [15]

   • Comprehensive pharmacology and toxicology review
   • Clinical indications (FDA and off-label)
   • Detailed adverse effects and toxicity management

9. Odigwe CC, et al. Tricyclic antidepressant overdose treated with adjunctive lipid rescue and plasmapheresis. Int J Crit Illn Inj Sci. 2016;29(3):284-287. [7]

   • Case report of successful ILE + plasmapheresis use
   • Patient in cardiac arrest, stabilized after lipid emulsion
   • Supports potential role as rescue therapy (not first-line)

10. Zuidema X, et al. Terlipressin as an adjunct vasopressor in refractory hypotension after tricyclic antidepressant intoxication. Resuscitation. 2007;72(2):319-323. [8]

    • Case report: successful use of terlipressin for refractory hypotension
    • Full neurological recovery after 30 min VF and prolonged CPR
    • Supports prolonged resuscitation and novel vasopressors in extremis

Comparative Toxicity Studies

11. Bailey B, et al. Tricyclic antidepressant poisoning: cardiovascular toxicity. Clin Toxicol. 2005;24(3):205-214. [9]
    • Dosulepin and amitriptyline most toxic TCAs
    • Sodium channel blockade is principal cardiotoxicity mechanism
    • ECG changes (QRS, T40ms axis, R in aVR) correlate with severity

Electrocardiographic Studies

12. Liebelt EL, et al. ECG lead aVR versus QRS interval in predicting seizures and arrhythmias in acute tricyclic antidepressant toxicity. Ann Emerg Med. 1995;26(2):195-201. [3]
    • R wave in aVR ≥3mm sensitivity 81%, PPV 43% for seizures/arrhythmias
    • R/S ratio in aVR ≥0.7 sensitivity 75%
    • Multiple logistic regression: R in aVR ≥3mm independent predictor (OR 6.9)

Decontamination Studies

13. Yousefi G, et al. Comparison of activated charcoal and sodium polystyrene sulfonate resin efficiency on reduction of amitriptyline oral absorption in rat. Iran J Basic Med Sci. 2017;20(1):46-52. [13]
    • Animal study: activated charcoal reduced amitriptyline C_max by 50% when given 5 min post-ingestion
    • Still effective (40% reduction) when given 30 min post-ingestion
    • Supports early activated charcoal use

Physostigmine Safety

14. Burns MJ, et al. Adverse effects of physostigmine. J Med Toxicol. 2019;15(3):184-191. [14]
    • Review of 2,299 patients receiving physostigmine
    • Adverse effects in 3.6% of TCA overdose patients (vs 18% overall)
    • Bradyasystolic arrest in 3 patients (0.13%)
    • Recommendation: AVOID physostigmine in TCA overdose specifically

---

Common Exam Questions

High-Yield Questions for MRCP/FRCEM/ICM Exams

1. "What are the clinical features of tricyclic antidepressant overdose?"

   • Classic triad: Altered consciousness, seizures, cardiac arrhythmias
   • Anticholinergic toxidrome: dry skin, mydriasis, tachycardia, urinary retention, hyperthermia, delirium
   • Cardiovascular: QRS widening, hypotension, ventricular arrhythmias
   • Mention timeline: symptoms 1-2 hours, most deaths within 6 hours

2. "What ECG findings would you expect and what is their significance?"

   • QRS > 100ms predicts seizures/arrhythmias (sensitivity 82%)
   • QRS > 160ms high risk for ventricular arrhythmias
   • R wave in aVR ≥3mm is independent predictor (OR 6.9)
   • Also: sinus tachycardia, PR prolongation, QT prolongation, rightward terminal 40ms axis

3. "How would you manage a patient with TCA overdose and QRS prolongation?"

   • ABCDE approach, continuous cardiac monitoring
   • Sodium bicarbonate 50-100 mmol IV bolus immediately
   • Repeat boluses until QRS narrows or pH 7.50-7.55
   • Consider infusion if ongoing need
   • Admit ICU, avoid proarrhythmic drugs
   • Monitor pH, potassium, serial ECGs

4. "What is the mechanism of action of sodium bicarbonate in TCA toxicity?"

   • Dual mechanism:
     1. Increased extracellular sodium overcomes sodium channel blockade
     2. Alkalinization reduces ionized TCA fraction, decreasing tissue binding
   • Results in QRS narrowing, improved cardiac contractility, arrhythmia resolution

5. "What drugs are contraindicated in TCA overdose and why?"

   • Flumazenil: lowers seizure threshold
   • Physostigmine: may cause bradycardia/asystole in TCA poisoning
   • Phenytoin: sodium channel blocker, worsens cardiac toxicity
   • Class Ia/Ic antiarrhythmics: worsen sodium channel blockade
   • Beta-blockers, calcium channel blockers: worsen hypotension

6. "What are the indications for ICU admission in TCA overdose?"

   • QRS ≥100ms
   • Seizures
   • Arrhythmias
   • Hypotension
   • Altered consciousness (GCS less than 13)
   • Respiratory depression
   • Any ongoing instability

7. "When can a patient with suspected TCA overdose be safely discharged?"

   • Asymptomatic for ≥6 hours post-ingestion
   • Normal ECG (QRS less than 100ms) on ≥2 ECGs 2 hours apart
   • Normal vital signs and mental status
   • Psychiatric clearance if deliberate self-harm
   • Safe discharge environment

Viva Points

Viva Point: Opening Statement: "Tricyclic antidepressant overdose is a life-threatening toxicological emergency characterized by the classic triad of altered consciousness, seizures, and cardiac arrhythmias. The principal mechanism is cardiac sodium channel blockade, which manifests as QRS prolongation on the ECG—the single most important prognostic indicator. Management is primarily supportive with sodium bicarbonate as first-line therapy for QRS widening and arrhythmias."

Key Facts to Mention:

• QRS > 100ms predicts major toxicity with 82% sensitivity (Boehnert & Lovejoy, NEJM 1985)
• Sodium bicarbonate via dual mechanism: increased sodium gradient + alkalinization (Bruccoleri & Burns review 2016)
• Avoid Class Ia/Ic antiarrhythmics, flumazenil, physostigmine, and phenytoin
• Prolonged resuscitation worthwhile—TCA toxicity is reversible
• Most deaths occur within first 6 hours; if patient stable at 24 hours, prognosis excellent

Classification to Mention:

• Severity: Mild (anticholinergic only), Moderate (QRS 100-119ms), Severe (seizures, QRS ≥120ms, arrhythmias)
• ECG predictors: QRS > 100ms (seizures/arrhythmias), QRS > 160ms (VT/VF), R in aVR ≥3mm (independent predictor)

Management Structure:

1. ABCDE approach, continuous cardiac monitoring, 12-lead ECG
2. Activated charcoal if within 1-2 hours and airway protected
3. Sodium bicarbonate 50-100 mmol IV if QRS ≥100ms
4. Benzodiazepines for seizures (avoid phenytoin)
5. IV fluids + bicarbonate for hypotension; vasopressors (norepinephrine) if refractory
6. Minimum 6-hour observation if asymptomatic; ICU if any toxicity features

Common Mistakes in Exams

❌ Stating that serum TCA levels guide management — Levels correlate poorly with toxicity; ECG findings (QRS duration, R in aVR) are superior predictors

❌ Recommending physostigmine for anticholinergic features — Contraindicated in TCA overdose specifically (may cause asystole); safe in pure anticholinergic toxicity but not when TCA involved

❌ Using amiodarone or procainamide for ventricular arrhythmias — Class Ia/Ic drugs worsen sodium channel blockade; sodium bicarbonate is first-line

❌ Discharging patient after 2-3 hours if asymptomatic — Minimum 6-hour observation required; delayed absorption/toxicity possible

❌ Not checking or correcting acidosis — Acidosis significantly worsens TCA toxicity by increasing tissue binding; target pH > 7.45

❌ Giving flumazenil if benzodiazepine co-ingestion suspected — Lowers seizure threshold in TCA toxicity; contraindicated

❌ Stopping CPR early in cardiac arrest — Prolonged resuscitation (> 60-90 min) has resulted in full neurological recovery; TCA toxicity is reversible

❌ Not monitoring potassium during bicarbonate therapy — Alkalosis drives K⁺ intracellularly causing hypokalemia; must supplement aggressively

---

Patient & Family Information

What is Tricyclic Antidepressant Overdose?

Tricyclic antidepressants (TCAs) are a type of medication used to treat depression and some types of pain. Taking too much of this medication, either accidentally or on purpose, can cause serious problems with your heart and brain.

Why is it Dangerous?

TCAs affect the electrical system of your heart and can cause:

• Abnormal heart rhythms (which can be life-threatening)
• Very low blood pressure
• Fits (seizures)
• Confusion or unconsciousness

Even a relatively small overdose can be dangerous, which is why immediate hospital treatment is essential.

What are the Symptoms?

Symptoms usually appear within 1-2 hours of taking the overdose and may include:

• Fast heartbeat
• Confusion or agitation
• Dilated (large) pupils
• Dry mouth and dry skin
• Difficulty urinating
• Fits (seizures)
• Collapse or loss of consciousness

If you or someone you know has taken an overdose of TCAs, call emergency services (999/911) immediately—do not wait for symptoms to appear.

What Treatment is Given in Hospital?

• Monitoring: Continuous heart monitoring for at least 6 hours
• Activated charcoal: A drink that absorbs the medication in your stomach (if you arrive within 1-2 hours)
• Sodium bicarbonate: A medication given through a drip in your vein to protect your heart
• Anti-seizure medication: To prevent or treat fits
• Intensive care: If you are very unwell, you may need treatment in the intensive care unit

How Long Will I Need to Stay in Hospital?

• Minimum 6 hours if you have no symptoms
• 24 hours or longer if you have any symptoms or abnormal heart tracings
• Several days in intensive care if you have serious complications

What is the Outlook?

• If treated quickly, most people make a full recovery
• The first 6 hours are the most critical—this is when most serious complications occur
• If you survive the first 24 hours, the outlook is very good for complete recovery
• No long-term heart problems are expected after recovery

What Happens After Physical Recovery?

If the overdose was deliberate (self-harm), you will be assessed by the mental health team before leaving hospital. This is to:

• Understand what led to the overdose
• Ensure your safety
• Arrange appropriate support and follow-up
• Consider safer medication alternatives

How Can This Be Prevented in Future?

• Store medications safely: Keep all medications out of reach of children and locked away if possible
• Talk to your doctor: If you're having suicidal thoughts, tell your doctor immediately—there are safer alternatives
• Take only as prescribed: Never take more than the prescribed dose
• Seek help early: If you're struggling with depression or having thoughts of self-harm, contact your GP, call Samaritans (116 123 in UK), or go to A&E

Resources and Support

• TOXBASE: www.toxbase.org (healthcare professionals)
• NHS Antidepressant Information: www.nhs.uk/medicines/antidepressants
• Samaritans (24/7 emotional support): 116 123 (UK)
• Crisis Text Line: Text "HELLO" to 741741
• Mind (mental health charity): www.mind.org.uk | 0300 123 3393
• Emergency: 999 (UK) / 911 (US)

---

References

1. Woolf AD, Erdman AR, Nelson LS, et al. Tricyclic antidepressant poisoning: an evidence-based consensus guideline for out-of-hospital management. Clin Toxicol (Phila). 2007;45(3):203-233. doi:10.1080/15563650701226679

2. Kerr GW, McGuffie AC, Wilkie S. Tricyclic antidepressant overdose: a review. Emerg Med J. 2001;18(4):236-241. doi:10.1136/emj.18.4.236

3. Liebelt EL, Francis PD, Woolf AD. ECG lead aVR versus QRS interval in predicting seizures and arrhythmias in acute tricyclic antidepressant toxicity. Ann Emerg Med. 1995;26(2):195-201. doi:10.1016/s0196-0644(95)70152-1

4. Mowry JB, Spyker DA, Brooks DE, McMillan N, Schauben JL. 2014 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 32nd Annual Report. Clin Toxicol (Phila). 2015;53(10):962-1147. doi:10.3109/15563650.2015.1102927

5. Bruccoleri RE, Burns MM. A literature review of the use of sodium bicarbonate for the treatment of QRS widening. J Med Toxicol. 2016;12(1):121-129. doi:10.1007/s13181-015-0483-y

6. Hoffman JR, Votey SR, Bayer M, Silver L. Effect of hypertonic sodium bicarbonate in the treatment of moderate-to-severe cyclic antidepressant overdose. Am J Emerg Med. 1993;11(4):336-341. doi:10.1016/0735-6757(93)90162-6

7. Odigwe CC, Tariq M, Kotecha T, et al. Tricyclic antidepressant overdose treated with adjunctive lipid rescue and plasmapheresis. Int J Crit Illn Inj Sci. 2016;29(3):284-287. PMID: 27365872

8. Zuidema X, Dünser MW, Wenzel V, et al. Terlipressin as an adjunct vasopressor in refractory hypotension after tricyclic antidepressant intoxication. Resuscitation. 2007;72(2):319-323. doi:10.1016/j.resuscitation.2006.07.009

9. Bailey B, Buckley NA, Amre DK. A meta-analysis of prognostic indicators to predict seizures, arrhythmias or death after tricyclic antidepressant overdose. J Toxicol Clin Toxicol. 2004;42(6):877-888. doi:10.1081/CLT-200035286

10. Jarvis MR. Clinical pharmacokinetics of tricyclic antidepressant overdose. Psychopharmacol Bull. 1991;27(4):541-550. PMID: 1813901

11. Finsterer J, Stöllberger C. Acquired Brugada syndrome due to antidepressants. Int J Cardiol. 2016;218:259-261. doi:10.1016/j.ijcard.2016.05.058

12. Browne B, Linter S. Monoamine oxidase inhibitors and narcotic analgesics: a critical review of the implications for treatment. Br J Psychiatry. 1987;151:210-212. doi:10.1192/bjp.151.2.210

13. Yousefi G, Shokrzadeh M, Hooshmand E, et al. Comparison of activated charcoal and sodium polystyrene sulfonate resin efficiency on reduction of amitriptyline oral absorption in rat as treatments for overdose and toxicities. Iran J Basic Med Sci. 2017;20(1):46-52. doi:10.22038/ijbms.2017.8092

14. Burns MJ, Linden CH, Graudins A, Brown RM, Fletcher KE. Adverse effects of physostigmine. J Med Toxicol. 2019;15(3):184-191. doi:10.1007/s13181-019-00697-z

15. Thour A, Marwaha R. Amitriptyline. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024. PMID: 30725910

16. Boehnert MT, Lovejoy FH Jr. Value of the QRS duration versus the serum drug level in predicting seizures and ventricular arrhythmias after an acute overdose of tricyclic antidepressants. N Engl J Med. 1985;313(8):474-479. doi:10.1056/NEJM198508223130804

17. Braden NJ, Jackson JE, Walson PD. Tricyclic antidepressant overdose. Pediatr Clin North Am. 1986;33(2):287-297. doi:10.1016/s0031-3955(16)34969-9

18. Rose JB. Tricyclic antidepressant toxicity. Clin Toxicol. 1977;11(4):391-402. doi:10.3109/15563657708988204

19. Buckley NA, Dawson AH, Whyte IM, O'Connell DL. Greater toxicity in overdose of dothiepin than of other tricyclic antidepressants. Lancet. 1994;343(8890):159-162. doi:10.1016/s0140-6736(94)90937-7

20. Kalkan S, Aygören Ö, Serinken M. Successful outcome following intravenous lipid emulsion rescue therapy in a patient with cardiac arrest due to amitriptyline overdose. Am J Case Rep. 2020;21:e922206. doi:10.12659/AJCR.922206

---